DWT
VKTX icon

Dorsey & Whitney Trust’s Viking Therapeutics VKTX Stock Holding History

Dorsey & Whitney Trust’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
29,871
-1
-0% -$32 0.06% 273
2026
Q1 		$972K Hold
29,872
– – 0.05% 303
2025
Q4 		$1.05M Buy
29,872
+9,425
+46% +$334K 0.06% 272
2025
Q3 		$537K Buy
20,447
+12,262
+150% +$366K 0.03% 409
2025
Q2 		$217K Buy
+8,185
New +$215K 0.01% 631
2024
Q4 		– Sell
-4,462
Closed -$282K – 707
2024
Q3 		$282K Buy
+4,462
New +$262K 0.02% 539
2024
Q1 		– Sell
-18,343
Closed -$341K – 643
2023
Q4 		$341K Buy
+18,343
New +$240K 0.03% 420

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dorsey & Whitney Trust's VKTX Position: Q2 2026 in Review

Dorsey & Whitney Trust reduced its Viking Therapeutics (VKTX) stake by 0% in Q2 2026, selling an estimated $32 and leaving 29,871 shares worth $1.17M. The position accounts for 0.06% of the portfolio, ranked #273.

Dorsey & Whitney Trust first reported a position in VKTX in Q4 2023 and has held it in 7 quarters since. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Dorsey & Whitney Trust held 29,871 shares of Viking Therapeutics worth $1.17M as of Q2 2026.
  • Dorsey & Whitney Trust sold 1 Viking Therapeutics share in Q2 2026, an estimated $32.
  • Viking Therapeutics made up 0.06% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #273 holding.
  • Dorsey & Whitney Trust first reported a position in Viking Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.